The peptidomimetic itself has an IC50 value of 0.3 to 0.8 μM in HER2 positive cancer cells, and lipidated peptidomimetic has IC50 of around 1 μM in HER2 positive cancer cell lines. This evidence concerns the gene ERBB2 and cancer.